FULGENT GENETICS, INC. Selling and Marketing Expense
FULGENT GENETICS, INC. (FLGT) reported Selling and Marketing Expense of $15.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-07-30
- FULGENT GENETICS, INC. selling and marketing expense for the quarter ending 2026-06-30 was $15.23M, a 23.95% increase year-over-year.
- FULGENT GENETICS, INC. selling and marketing expense for the quarter ending 2026-03-31 was $12.22M, a 44.37% increase year-over-year.
- FULGENT GENETICS, INC. selling and marketing expense for the quarter ending 2025-12-31 was $10.98M, a 15.10% increase year-over-year.
- FULGENT GENETICS, INC. selling and marketing expense for the quarter ending 2025-09-30 was $11.64M, a 27.60% increase year-over-year.
- FULGENT GENETICS, INC. selling and marketing expense for fiscal 2025 was $43.37M, a 19.66% increase from fiscal 2024.
- FULGENT GENETICS, INC. selling and marketing expense for fiscal 2024 was $36.25M, a 12.59% decline from fiscal 2023.
- FULGENT GENETICS, INC. selling and marketing expense for fiscal 2023 was $41.47M, a 6.55% increase from fiscal 2022.
- FULGENT GENETICS, INC. selling and marketing expense for fiscal 2022 was $38.92M, a 59.25% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.23M 10-Q · filed 2026-07-30 | $27.45M 10-Q · filed 2026-07-30 | $38.43M derived: sum of 3 quarters · filed 2026-07-30 | $50.07M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $12.22M 10-Q · filed 2026-05-01 | $23.20M derived: sum of 2 quarters · filed 2026-05-01 | $34.84M derived: sum of 3 quarters · filed 2026-05-01 | $47.13M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $10.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.62M derived: sum of 2 quarters · filed 2026-02-27 | $34.91M derived: sum of 3 quarters · filed 2026-07-30 | $43.37M 10-K · filed 2026-02-27 |
| 2025-09-30 | $11.64M 10-Q · filed 2025-11-07 | $23.93M derived: sum of 2 quarters · filed 2026-07-30 | $32.39M 10-Q · filed 2025-11-07 | $41.93M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $12.29M 10-Q · filed 2026-07-30 | $20.75M 10-Q · filed 2026-07-30 | $30.29M derived: sum of 3 quarters · filed 2026-07-30 | $39.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $8.46M 10-Q · filed 2026-05-01 | $18.00M derived: sum of 2 quarters · filed 2026-05-01 | $27.13M derived: sum of 3 quarters · filed 2026-05-01 | $35.72M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $9.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $18.66M derived: sum of 2 quarters · filed 2026-02-27 | $27.26M derived: sum of 3 quarters · filed 2026-02-27 | $36.25M 10-K · filed 2026-02-27 |
| 2024-09-30 | $9.12M 10-Q · filed 2025-11-07 | $17.72M derived: sum of 2 quarters · filed 2025-11-07 | $26.71M 10-Q · filed 2025-11-07 | $37.21M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $8.60M 10-Q · filed 2025-08-01 | $17.58M 10-Q · filed 2025-08-01 | $28.08M derived: sum of 3 quarters · filed 2026-02-27 | $38.24M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $8.99M 10-Q · filed 2025-05-02 | $19.49M derived: sum of 2 quarters · filed 2026-02-27 | $29.65M derived: sum of 3 quarters · filed 2026-02-27 | $40.37M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $10.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $20.66M derived: sum of 2 quarters · filed 2026-02-27 | $31.38M derived: sum of 3 quarters · filed 2026-02-27 | $41.47M 10-K · filed 2026-02-27 |
| 2023-09-30 | $10.16M 10-Q · filed 2024-11-08 | $20.88M derived: sum of 2 quarters · filed 2024-11-08 | $30.97M 10-Q · filed 2024-11-08 | $41.22M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $10.72M 10-Q · filed 2024-08-02 | $20.81M 10-Q · filed 2024-08-02 | $31.06M derived: sum of 3 quarters · filed 2024-08-02 | $40.92M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $10.08M 10-Q · filed 2024-05-03 | $20.34M derived: sum of 2 quarters · filed 2024-05-03 | $30.20M derived: sum of 3 quarters · filed 2024-05-03 | $41.06M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $10.25M 10-K · filed 2023-02-28 | $20.11M derived: sum of 2 quarters · filed 2023-11-03 | $30.98M derived: sum of 3 quarters · filed 2023-11-03 | $38.92M 10-K · filed 2025-02-28 |
| 2022-09-30 | $9.86M 10-Q · filed 2023-11-03 | $20.73M derived: sum of 2 quarters · filed 2023-11-03 | $28.66M 10-Q · filed 2023-11-03 | $36.87M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $10.87M 10-Q · filed 2023-08-04 | $18.81M 10-Q · filed 2023-08-04 | $27.01M derived: sum of 3 quarters · filed 2023-08-04 | $33.02M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $7.94M 10-Q · filed 2023-05-05 | $16.14M derived: sum of 2 quarters · filed 2023-05-05 | $22.15M derived: sum of 3 quarters · filed 2023-05-05 | $27.37M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $8.20M 10-K · filed 2023-02-28 | $14.21M derived: sum of 2 quarters · filed 2023-02-28 | $19.43M derived: sum of 3 quarters · filed 2023-02-28 | $24.44M 10-K · filed 2024-02-28 |
| 2021-09-30 | $6.01M 10-K · filed 2023-02-28 | $11.23M derived: sum of 2 quarters · filed 2023-02-28 | $16.24M 10-Q · filed 2022-11-07 | $21.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $5.22M 10-K · filed 2023-02-28 | $10.23M 10-Q · filed 2022-08-04 | $15.31M derived: sum of 3 quarters · filed 2023-02-28 | $20.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $5.01M 10-K · filed 2023-02-28 | $10.09M derived: sum of 2 quarters · filed 2023-02-28 | $15.10M derived: sum of 3 quarters · filed 2023-02-28 | $18.36M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $5.08M 10-K · filed 2022-02-28 | $10.10M derived: sum of 2 quarters · filed 2022-02-28 | $13.36M derived: sum of 3 quarters · filed 2022-02-28 | $14.95M 10-K · filed 2023-02-28 |
| 2020-09-30 | $5.01M 10-K · filed 2022-02-28 | $8.27M derived: sum of 2 quarters · filed 2022-02-28 | $9.87M 10-Q · filed 2021-11-09 | $11.51M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $3.26M 10-K · filed 2022-02-28 | $4.86M 10-Q · filed 2021-08-10 | $6.49M derived: sum of 3 quarters · filed 2022-02-28 | $8.18M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.60M 10-K · filed 2022-02-28 | $3.23M derived: sum of 2 quarters · filed 2022-02-28 | $4.92M derived: sum of 3 quarters · filed 2022-02-28 | $6.22M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.64M 10-K · filed 2021-03-08 | $3.32M derived: sum of 2 quarters · filed 2021-03-08 | $4.63M derived: sum of 3 quarters · filed 2021-03-08 | $5.90M 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.69M 10-K · filed 2021-03-08 | $2.99M derived: sum of 2 quarters · filed 2021-03-08 | $4.26M 10-Q · filed 2020-11-09 | $5.39M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $1.30M 10-K · filed 2021-03-08 | $2.58M 10-Q · filed 2020-08-05 | $3.70M derived: sum of 3 quarters · filed 2021-03-08 | $4.82M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $1.27M 10-K · filed 2021-03-08 | $2.40M derived: sum of 2 quarters · filed 2021-03-08 | $3.52M derived: sum of 3 quarters · filed 2021-03-08 | $4.79M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $1.13M 10-K · filed 2020-03-13 | $2.24M derived: sum of 2 quarters · filed 2020-03-13 | $3.52M derived: sum of 3 quarters · filed 2020-03-13 | $4.65M 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.11M 10-K · filed 2020-03-13 | $2.39M derived: sum of 2 quarters · filed 2020-03-13 | $3.52M 10-Q · filed 2019-11-08 | $4.60M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $1.28M 10-K · filed 2020-03-13 | $2.41M 10-Q · filed 2019-08-12 | $3.49M derived: sum of 3 quarters · filed 2020-03-13 | $4.87M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $1.13M 10-K · filed 2020-03-13 | $2.21M derived: sum of 2 quarters · filed 2020-03-13 | $3.59M derived: sum of 3 quarters · filed 2020-03-13 | $4.44M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $1.08M 10-K · filed 2019-03-22 | $2.46M derived: sum of 2 quarters · filed 2019-03-22 | $3.31M derived: sum of 3 quarters · filed 2019-03-22 | $4.21M 10-K · filed 2019-03-22 |
| 2017-09-30 | $1.38M 10-K · filed 2019-03-22 | $2.23M derived: sum of 2 quarters · filed 2019-03-22 | $3.13M 10-Q · filed 2018-11-09 | $3.92M derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-06-30 | $851.00K 10-K · filed 2019-03-22 | $1.74M 10-Q · filed 2018-08-13 | $2.54M derived: sum of 3 quarters · filed 2019-03-22 | $3.43M derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-03-31 | $891.00K 10-K · filed 2019-03-22 | $1.69M derived: sum of 2 quarters · filed 2019-03-22 | $2.58M derived: sum of 3 quarters · filed 2019-03-22 | $3.06M derived: sum of 4 quarters · filed 2019-03-22 |
| 2016-12-31 | $798.00K 10-K · filed 2018-03-20 | $1.69M derived: sum of 2 quarters · filed 2018-03-20 | $2.17M derived: sum of 3 quarters · filed 2018-03-20 | $2.47M 10-K · filed 2018-03-20 |
| 2016-09-30 | $893.00K 10-K · filed 2018-03-20 | $1.37M derived: sum of 2 quarters · filed 2018-03-20 | $1.67M 10-Q · filed 2017-11-13 | $3.58M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | $477.00K 10-K · filed 2018-03-20 | $778.00K 10-Q · filed 2017-08-14 | $2.69M derived: sum of 3 quarters · filed 2018-03-20 | $2.97M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-03-31 | $301.00K 10-K · filed 2018-03-20 | $2.21M derived: sum of 2 quarters · filed 2018-03-20 | $2.49M derived: sum of 3 quarters · filed 2018-03-20 | $2.74M derived: sum of 4 quarters · filed 2018-03-20 |
| 2015-12-31 | $1.91M 10-K · filed 2017-03-17 | $2.19M derived: sum of 2 quarters · filed 2017-03-17 | $2.44M derived: sum of 3 quarters · filed 2017-03-17 | $2.67M 10-K · filed 2017-03-17 |
| 2015-09-30 | $280.00K 10-K · filed 2017-03-17 | $523.00K derived: sum of 2 quarters · filed 2017-03-17 | $757.00K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $243.00K 10-K · filed 2017-03-17 | $477.00K derived: sum of 2 quarters · filed 2017-03-17 | ||
| 2015-03-31 | $234.00K 10-K · filed 2017-03-17 | |||
| 2014-12-31 | $581.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |